根據最新的財務報表(Form-10K),Oncology Institute Inc 的總資產為 $164,淨損失為 $-50
TOI 的關鍵財務比率是什麼?
Oncology Institute Inc 的流動比率為 0.91,淨利潤率為 -9.96,每股銷售為 $5.43。
Oncology Institute Inc 的收入按細分市場或地理位置如何劃分?
Oncology Institute Inc 最大收入來源為 Patient Services,在最近的收益報告中收入為 213,504,000。就地區而言,United States 是 Oncology Institute Inc 的主要市場,收入為 324,239,000。
Oncology Institute Inc 是否盈利?
無,根據最新的財務報表,Oncology Institute Inc 的淨損失為 $-50
Oncology Institute Inc 有負債嗎?
是的,Oncology Institute Inc 的負債為 180
Oncology Institute Inc 的流通股有多少?
Oncology Institute Inc 的總流通股為 98.86
關鍵數據
前收市價
$3.12
開盤價
$3.13
當日範圍
$3.12 - $3.34
52週區間
$1.14 - $4.88
交易量
713.8K
平均成交量
2.0M
股息收益率
--
每股盈餘 (TTM)
-0.68
市值
$322.7M
什麼是 TOI?
The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California and currently employs 641 full-time employees. The company went IPO on 2020-03-13. The firm manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The firm's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The firm also provides management services to over 14 clinic locations owned by independent oncology practices. The firm and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.